---
layout: archive
title: "CV"
permalink: /cv/
author_profile: true
redirect_from:
  - /resume
---

{% include base_path %}


# ðŸ‘‹ Hi, Iâ€™m Poornachandra G.

**Lead Scientist â€“ Clinical Translation & Precision Medicine in Oncology**  
ðŸ“ Bengaluru, India  
âœ‰ï¸ [poornachandra.gedi@gmail.com](mailto:poornachandra.gedi@gmail.com) â€¢ â˜Žï¸ +91 7899 419758  
ðŸ”— [LinkedIn](https://linkedin.com/in/poornachandra-g) â€¢ [ORCID](https://orcid.org/0009-0009-1610-1205)

---

## ðŸ§¬ About Me

Iâ€™m a **Bioinformatics Lead Scientist** with over a decade of experience in precision oncology, clinical genomics, and computational biology. My passion lies in **building intelligent pipelines**, **translating multi-omics data into actionable insights**, and **making a real-world impact in patient care**.

Over the past 10+ years at **Cellworks**, Iâ€™ve helped shape our bioinformatics capabilities from the ground up â€” from designing scalable secondary analysis workflows to developing clinical decision support systems, integrating machine learning, and mentoring a growing team of scientists.

---

## ðŸš€ What Iâ€™m Known For

- ðŸ§ª **Production-grade pipelines:** Built and deployed end-to-end NGS workflows (WGS, WES, TES, RNA-seq, CNV, SV) that power both clinical and research programs.
- ðŸ§  **Variant intelligence:** Architected annotation and prioritization systems aligned with ACMG/AMP/ASCO/CAP standards.
- ðŸ¤– **AI in genomics:** Led ML-driven biomarker discovery and patient stratification projects, from feature engineering to deployment.
- ðŸ‘©â€ðŸ”¬ **Leadership:** Mentored and scaled bioinformatics teams, led hiring, and created training programs that boosted team performance.
- ðŸ§° **Beyond pipelines:** Delivered internal tools and dashboards (Streamlit, Gradio) to make complex bioinformatics workflows interactive and user-friendly.

---

## ðŸ§‘â€ðŸ”¬ Core Competencies

- **Clinical Genomics:** Variant interpretation (ACMG/AMP/ASCO/CAP), Pharmacogenomics, Liquid Biopsy, Companion Diagnostics  
- **Pipeline Engineering:** GATK Best Practices, Sentieon, DRAGEN, Parabricks, Nextflow, QC Automation  
- **Machine Learning:** Feature Engineering, Biomarker Discovery, Model Validation, Ensemble Methods  
- **Leadership & Strategy:** Team Building, Project Roadmaps, Regulatory Compliance, Stakeholder Communication  

---

## ðŸ§° Technical Toolkit

**NGS Analysis:** GATK â€¢ Sentieon â€¢ DRAGEN â€¢ Parabricks â€¢ FreeBayes â€¢ DeepVariant â€¢ PureCN â€¢ CNVKit â€¢ VEP â€¢ ANNOVAR  
**RNA & Single-Cell:** Kallisto â€¢ Salmon â€¢ DESeq2 â€¢ edgeR â€¢ Seurat â€¢ Scanpy â€¢ GSEA  
**Cloud & Pipelines:** DNAnexus â€¢ AWS â€¢ BaseSpace â€¢ Galaxy â€¢ Terra â€¢ ICA  
**ML/AI Stack:** Hugging Face â€¢ LangChain â€¢ Ollama â€¢ OpenAI / Gemini APIs â€¢ LightGBM â€¢ PyTorch â€¢ scikit-learn â€¢ BioBERT  
**DevOps & Workflow:** Docker â€¢ Nextflow â€¢ Jupyter â€¢ Git â€¢ HPC â€¢ Conda  
**Visualization & Tools:** Streamlit â€¢ Gradio â€¢ Plotly â€¢ Matplotlib â€¢ Seaborn

---

## ðŸ’¼ Professional Experience

### ðŸ§ª Lead Bioinformatician â€” Cellworks (2024 â€“ Present)
- Defined the teamâ€™s technical roadmap and strategic priorities.
- Built annotation & prioritization frameworks applying AMP/ASCO/CAP guidelines.
- Led risk management initiatives for pipelines and improved process robustness.
- Introduced structured upskilling and team growth initiatives.

### ðŸ”¬ Senior Scientist & Reporting Manager â€” Cellworks (2022 â€“ 2024)
- Built high-throughput variant calling stacks on AWS and multi-omics interpretation pipelines.
- Recruited, mentored, and led a team of 4 scientists.
- Designed input-agnostic workflows across multiple data formats and vendors.
- Developed databases across 30+ cancer types to power driver mutation analysis.

### ðŸ§« Senior Scientist, Bioinformatics â€” Cellworks (2018 â€“ 2021)
- Designed secondary analysis workflows with DRAGEN, Parabricks, and Psomagen.
- Developed biomarker pipelines and ML models for early relapse prediction in melanoma.
- Built comprehensive tertiary analysis workflows (GSEA, ML, PCA, enrichment).
- Led large-scale biomarker analyses on >18,000 Foundation Medicine cases.

### ðŸ”Ž Scientist, Clinical Translation â€” Cellworks (2017 â€“ 2018)
- Curated rationale libraries, reducing turnaround time by 40%.
- Conducted 200+ clinical case analyses and implemented custom variant-tier classification.
- Benchmarked sequencing pipelines and built annotation/filtering pipelines.

### ðŸ§¬ Associate Scientist â€” Cellworks (2015 â€“ 2017)
- Processed and harmonized multi-omics data across >500 cases.
- Integrated large-scale datasets (TCGA, GDSC, published studies) into internal databases.
- Automated ETL pipelines and report generation workflows, saving 15+ hours weekly.

---

## ðŸŽ“ Education

**B.Tech, Biotechnology** â€” JNTUA College of Engineering Pulivendula, 2015

---

## ðŸ¤– Selected AI & Data Projects

- **Evaline:** AI chatbot integrating fine-tuned LLM + RAG for clinical guideline recommendations.  
- **PathoParse:** NLP pipelines to extract structured metadata from pathology reports.  
- **SQL Chat:** Multi-agent Streamlit tool translating clinical queries into SQL with built-in stats testing.  
- **VarEffex:** Literature mining system to extract variantâ€“function relationships.

---

## ðŸ“š Selected Publications

- Castro M, Pampana A, Alam A, *et al.* *J. Neuro-Oncology* (2021): Combination chemotherapy vs. temozolomide in MGMT+ GBM.  
- Ahluwalia MS, Watson D, Kapoor S, *et al.* *J. Clin. Oncol* (2020): Superior therapy response predictions in low-grade glioma.  
- Marcucci G, Kumar A, Castro M, *et al.* *Blood* (2021): Biosimulation identifies novel MEC therapy biomarkers.  
- Howard SC, Nair PR, Grover H, *et al.* *Blood* (2020): Predicting resistance to ATO and ATRA in APL.  
- Castro M, Iwamoto F, Ahluwalia M, *et al.* *Neuro-Oncology* (2022): Impact of mismatch repair deficiency in GBM survival.

---

## ðŸŒŸ Final Note

Iâ€™ve spent my career building pipelines, platforms, and teams that turn complex biological data into clinical insights â€” and Iâ€™m just getting started. Whether itâ€™s leading large-scale bioinformatics initiatives, mentoring the next generation of scientists, or bringing AI into clinical genomics, Iâ€™m passionate about driving science from **data â†’ decision â†’ patient impact**.


